Does concomitant methotrexate confer clinical benefits in patients treated with prior biologic therapy? Analysis of data from a noninterventional study of rheumatoid arthritis patients initiating treatment with adalimumab

Most studies of methotrexate (MTX) in combination with tumor necrosis factor (TNF) inhibitors have focused on treatment-naive patients with early disease. The goal of this study was to evaluate whether previous biologic therapy influenced the impact of concomitant MTX in patients initiating treatmen...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Medicine (Baltimore)
Autors principals: Schmalzing, Marc, Behrens, Frank, Schwaneck, Eva C., Koehm, Michaela, Greger, Gerd, Gnann, Holger, Burkhardt, Harald, Tony, Hans-Peter
Format: Artigo
Idioma:Inglês
Publicat: Wolters Kluwer Health 2020
Matèries:
6900
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7220320/
https://ncbi.nlm.nih.gov/pubmed/32384515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000020201
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars